CIT-Logo-White Created with Sketch.

MENU
Device Guides
Trial Guide
Centers
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

Funding for this supplement provided by Medtronic

cit | Article | November/December 2016 Supplement

TAVR Economics in a Community Program

By Hemal Gada, MD, MBA, and Mubashir Mumtaz, MD, FACS, FACC, on behalf of PinnacleHealth CardioVascular Institute, Harrisburg, PA

cit | Article | September/October 2019

TAVR in Small Anatomy

Moderator: Matias Sztejfman, MD
Panelists: Guilherme Attizzani, MD; Cristian Baeza, MD; Hemal Gada, MD, MBA; Anthony Main, MD; and Henrique Barbosa Ribeiro, MD, PhD

Sponsored by Pi-Cardia

cit | Article | January/February 2025

ShortCut™: Simplifying Complex TAVR With Leaflet Modification

With commentary from Hemal Gada, MD; Philippe Généreux, MD; and Thomas E. Waggoner, DO, FACC

cit | Article | March/April 2025

Literature Highlights: Study Endpoint Finds Early TAVR Superior to Clinical Surveillance for Asymptomatic, Severe Aortic Stenosis

With Hemal Gada, MD

Advertisement

Funding for this supplement provided by Medtronic

cit | Article | January/February 2021 Supplement

Procedural Optimization to Minimize Interaction With the Left Ventricular Conduction System During Self-Expanding TAVR

The inception of the cusp overlap technique: rationale and development.

By Hemal Gada, MD, MBA, and Amit N. Vora, MD, MPH

cit | Article | September/October 2025

TAVR in Complex Anatomies

Experts share their insights on performing TAVR in bicuspid aortic valves, valve-in-valve procedures, and small aortic annuli, focusing on imaging techniques, valve sizing, procedural risks, and emerging data.

With Toby Rogers, MD; Hemal Gada, MD; Gilbert Tang, MD, MSc, MBA; Christopher Bruce, MD; and Jeremy D. Rier, DO, FACC, FSCAI

cit | News | March 30, 2016

Enrollment Begins in Trial of Medtronic's CoreValve Evolut R TAVR System in Low-Risk Patients

March 31, 2016—Medtronic plc announced that the first patients were enrolled in the expanded indication trial for the CoreValve Evolut R system, the company’s next-generation, recapturable, self-expanding transcatheter aortic valve replacement (TAVR) system.

cit | News | October 8, 2024

Emblok Evaluates Whole-Body Embolic Protection System for TAVR Procedures

October 8, 2024—Emblok announced that it has enrolled the first 50 patients in a clinical trial to evaluate the performance and treatment effect of its Emblok embolic protection system (EPS).

cit | Article | September/October 2025

State of the Art in Valvular Disease

By Triston Smith, MD, MGM, and Ranya Sweis, MD, MSc

cit | News | June 3, 2019

Early Feasibility Study Begins for Ancora Heart's AccuCinch Transcatheter Heart Failure Therapy

June 3, 2019—Ancora Heart, Inc. announced the first patient was enrolled in a United States early feasibility study evaluating the company's AccuCinch ventricular repair system as a treatment for patients with reduced ejection fraction systolic heart failure.

cit | Article | September/October 2019

Meeting the Challenge…

By Azeem Latib, MD

cit | News | May 31, 2024

Half Moon Medical’s Pilot Study of TMVR System Continues Enrollment

May 31, 2024—Half Moon Medical announced the treatment of 15 patients with the second-generation Half Moon transcatheter mitral valve repair (TMVR) device.

cit | Article | March/April 2025

Emerging Options for Aortic Regurgitation

By Matti Adam, MD, and Jonathan Curio, MD

Advertisement

Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button